PROTOCOLREFERENCE OUTLINE

Cleaning Validation Protocol

Cleaning validation protocol with worst-case grouping, HBEL/PDE-based residue limits, swab/rinse sampling and recovery, and acceptance criteria. Maps to EU GMP Annex 15 and 21 CFR 211.67.

What a template is not

A template is a document baseline to adapt inside your own quality system. SPEQ does not approve, validate, or take responsibility for what you issue from it, and using one is not evidence of compliance.

CHECKING ACCESS

Checking your Professional access…

REGULATIONS MAPPED
EU GMP Annex 1521 CFR Part 211PDA TR 29
DOCUMENT TYPE
Protocol
LAST UPDATED
January 2025
PURPOSE

A protocol establishing documented evidence that a cleaning process consistently removes product, cleaning-agent, and microbial residues to limits derived from health-based exposure data. The hardest part is not the execution but the limit: it must be derived from a defensible toxicological basis and the real equipment train, and this protocol is where that derivation is written down and approved.

What's Inside

Product and equipment grouping with the worst-case selection and the criteria that produced it
Residue limit derivation from health-based exposure limits, with the shared surface area and batch sizes used
Cleaning-agent and microbial limits alongside the product-residue limit
Sampling strategy — swab locations chosen on hardest-to-clean rationale, plus rinse sampling where surfaces are inaccessible
Analytical methods, detection limits, and the recovery study that makes swab results meaningful
Acceptance criteria per residue type and the number of runs, with the basis for the run count
Execution records, results, conclusion, and the ongoing monitoring strategy after validation

How to Use It

1Group products and equipment, then select the worst case against stated criteria rather than by assertion
2Derive limits from the health-based exposure limit, the shared surface area, and the smallest following batch — and show the arithmetic
3Choose swab locations on hardest-to-clean rationale, and use rinse sampling only where a surface cannot be swabbed
4Run the recovery study before execution; a swab result without a recovery factor is not a residue measurement
5Set per-residue acceptance criteria and justify the run count instead of defaulting to three
6Define the ongoing monitoring that follows validation, including what result would trigger revalidation
DOCUMENT CONTENTS

The full section structure of this template — every section and sub-section, so you can use it as a baseline for your own site document.

Document Control
Document InformationApproval SignaturesRevision HistoryDistribution List
1Purpose, Scope, and Equipment Train
2Worst-Case Product and Equipment Grouping
3Residue Limit Derivation (HBEL / MACO)
4Sampling Strategy (Swab and Rinse)
5Analytical Methods and Recovery
6Acceptance Criteria and Number of Runs
7Execution and Sampling Records
8Results, Conclusion, and Approval
REGULATORY CONTEXT

EU GMP Annex 15 requires cleaning validation with limits based on toxicological evaluation, and the EMA guideline on health-based exposure limits sets the framework for deriving those limits for shared facilities. 21 CFR 211.67 requires equipment to be cleaned and maintained to prevent contamination that would alter safety, identity, strength, quality, or purity. PDA Technical Report 29 informs the practical sampling design here and is industry guidance, not regulation. The limits and the worst case you adopt are your determination.

MAPPED STANDARDS
EU GMP Annex 1521 CFR Part 211PDA TR 29
Browse the standards catalog →